The Patent Finder

Corbus Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Corbus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to Corbus Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 10,085,964Ultrapure TETRAHYDROCANNABINOL-11-OIC Acids
Lapsed on the fee record
Ended Oct 2, 2026 · Medium confidence
Lapsed on the fee recordEnded Oct 2, 2026Medium confidence
US 8,637,087Treatment of interstitial cystitis using (6aR, 10aR)-Δ8-tetrahydrocannabinol-11-OIC acids
Term ended
Term ended Dec 13, 2025 · From the USPTO record
Term endedTerm ended Dec 13, 2025From the USPTO record
US 9,820,964Ultrapure TETRAHYDROCANNABINOL-11-OIC Acids
Formerly held
Lapsed on the fee record
Ended Nov 21, 2025 · Medium confidence
Lapsed on the fee recordEnded Nov 21, 2025Medium confidence
US 9,801,849Ultrapure TETRAHYDROCANNABINOL-11-OIC Acids
Lapsed on the fee record
Ended Oct 31, 2025 · Medium confidence
Lapsed on the fee recordEnded Oct 31, 2025Medium confidence
US 11,052,066Ultrapure TETRAHYDROCANNABINOL-11-OIC Acids
Formerly held
Lapsed on the fee record
Ended Jul 6, 2025 · Medium confidence
Lapsed on the fee recordEnded Jul 6, 2025Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited